Sort
82,697 grants matching “vaccine development”
VACCINATION FOR TREATMENT OF NICTOTINE DEPENDENCE
$1,031,569Nabi Biopharmaceuticals · U19 · FY2002 · DA
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
$1,031,446Kathleen Schmeler · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Assessment of the Immunogenicity and Protective Efficacy of a Multiagent DNA Vacc
$1,031,332Connie Schmaljohn · Geneva Foundation · U01 · FY2010 · AI
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$1,031,297Barton F Haynes · Duke University · U19 · FY2019 · AI
DNA Vaccines
$1,031,160George N. Pavlakis · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$1,030,988Kathy L Rowlen · Indevr, Inc. · R44 · FY2015 · AI
ANTIGEN-SPECIFIC VACCINES FOR BREAST CANCER
$1,030,900Johns Hopkins University · U19 · FY2002 · CA
Establishment/Maintenance of Biomedical Research Colony
$1,030,597Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2009 · RR
Development of Hepatitis C Virus Inhibitors
$1,030,553Glen Andrew Coburn · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · AI
Impact of gene-drive systems for population modification on malaria vector mosquitoes
$1,030,493Anthony A James · University Of California-Irvine · R01 · FY2025 · AI
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
$1,030,346Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Fogarty AIDS International Training and Research Program (AITRP)
$1,030,138Chris Beyrer · Johns Hopkins University · D43 · FY2009 · TW
AIDS Animal Models: Cellular Immunology and Immunogenetics
$1,029,849Bernard Lafont · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Papillomavirus Virion Proteins and Vaccines
$1,029,658Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Core 3: Biocontainment Research Support Services Core
$1,029,538Colin S. Duckett · Duke University · UC7 · FY2023 · AI
Immune correlates of protection
$1,029,324Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,029,324Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Influence of SIV replication on TB progression and immunity
$1,029,305Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Clinical and translational evaluation of vaccination strategies for Zika, Chikungunya, Dengue, Leishmania, Malaria, and other important or emerging vector-borne diseases
$1,029,125Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
$1,028,842Lyndsey Linke · Sivec Biotechnologies, Llc · R44 · FY2020 · AI
Experimental characterization of the dynamics of immune responses to influenza
$1,028,598Rafi Ahmed · Emory University · U19 · FY2016 · AI
INDâenabling development of MMâ008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring
$1,028,445Richard A Cone · Mucommune, Llc · R44 · FY2023 · HD
Interaction of HIV envelope with cell surface receptors
$1,028,402James L Arthos · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$1,028,402Claudia Cicala · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$1,028,395Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2025 · CA